Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012-2019

Am J Public Health. 2023 Feb;113(2):162-165. doi: 10.2105/AJPH.2022.307152. Epub 2022 Dec 8.

Abstract

To determine whether the Veterans Health Administration's (VHA) hepatitis C (HCV) treatment campaign reached marginalized populations, we compared HCV care by previous incarceration status with Veterans Aging Cohort Study data. Of those with and those without previous incarceration, respectively, 40% and 21% had detectable HCV, 59% and 65% underwent treatment (P = .07); 92% and 94% of those who completed treatment achieved sustained virologic response. The VHA HCV treatment effort was successful and other systems should replicate those efforts. (Am J Public Health. 2023;113(2):162-165. https://doi.org/10.2105/AJPH.2022.307152).

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antiviral Agents / therapeutic use
  • Cohort Studies
  • Hepacivirus
  • Hepatitis C* / drug therapy
  • Humans
  • United States / epidemiology
  • United States Department of Veterans Affairs
  • Veterans Health
  • Veterans*

Substances

  • Antiviral Agents